OLK News and Press, Olink Holding AB (publ)

UPPSALA, Sweden, July 05, 2024 (GLOBE NEWSWIRE) -- At the Extra General Meeting (the “EGM”) of Olink Holding AB (publ), reg. no 559189-7755, (the “Company”), the EGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents ...

UPPSALA, Sweden, July 03, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK), a global leader in proteomics, introduces its inaugural network of Olink ® Certified Service Providers. The group of Olink Certified Service Providers represent leading contract research organizatio...

2024-07-02 12:51:20 ET More on Olink Olink gains after receiving German approval for sale to Thermo Fisher Olink drops after UK antitrust regulator starts review of Thermo Fisher deal Seeking Alpha’s Quant Rating on Olink Historical earnings data for O...

2024-06-17 21:49:22 ET More on Olink, Thermo Fisher Scientific, etc. Low Yield, High Growth: Unveiling The Power Of Thermo Fisher's Dividends Thermo Fisher Scientific Inc. (TMO) Presents at Bank of Bank of America Securities 2024 Health Care Conference (Transcript) T...

2024-06-13 17:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail. UPPSALA, Sweden, June 11, 2024 (GLOBE NEWSWIRE) -- The shareholders of Olink Holding AB (publ) (the “Company”), reg. no. 5...

UPPSALA, Sweden, June 06, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink Target 48 Immune Surveillance, a validated multiplexed protein assay panel that offers a detailed view of the immune system for in-depth monitoring of inflammation an...

UPPSALA, Sweden, May 30, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today reported the publication of a landmark study using the Olink Explore platform to identify proteins in the blood that may provide a 7-year warning for various cancers. The findings, published in N...

2024-05-23 09:17:40 ET Summary Lab Instrument and Services providers in the healthcare industry can generate high recurring revenues. Many loss-making instrument makers in the industry may not provide meaningful returns and carry high risks. Cytek stands out as the best opport...

2024-05-13 09:12:19 ET More on Olink Olink drops after UK antitrust regulator starts review of Thermo Fisher deal Olink GAAP EPS of -$0.06 misses by $0.22, revenue of $68.6M misses by $21.27M Seeking Alpha’s Quant Rating on Olink Historical earnings da...